TOMI Environmental Solutions, Inc. Reports First Quarter 2025 Results

Rhea-AI Summary

TOMI Environmental Solutions (NASDAQ: TOMZ) reported improved Q1 2025 financial results with net sales of $1.58M, up 42% from Q1 2024. The company reduced its net loss to $(256,000) or $(0.01) per share, compared to $(1.31M) or $(0.07) per share in Q1 2024. Gross margin remained stable at 60.4%. Key highlights include: - 197% growth in SteraMist BIT solution sales - 80% increase in domestic revenue to $1.19M - Service revenue up 56% to $577,000 - Sales backlog of $1.23M, up $348,000 from December 2024 Notable developments include a $450,000 contract for a SteraMist system at a Rhode Island university, deployment at NASA Johnson Space Center, and new OEM partnership with PBSC. The company expects positive trends to continue throughout 2025.

Positive

• Net sales increased 42% year-over-year to $1.58M
• Net loss significantly reduced to $256,000 from $1.31M year-over-year
• Strong 197% growth in SteraMist BIT solution sales
• Secured $450,000 contract with Rhode Island university
• Expanded into aerospace sector through NASA partnership
• Sales backlog increased by $348,000 from December 2024

Negative

• Company still operating at a loss with $(754,000) operating loss
• Operating expenses remain high at $1.71M despite reduction from previous year

Insights

Financial Analyst

TOMI's Q1 shows 42% revenue growth and 80% narrower losses, with promising new contracts and sector diversification signaling potential turnaround.

TOMI Environmental Solutions has delivered a 42% year-over-year revenue increase to $1.58 million in Q1 2025, indicating significant momentum in their disinfection technology business. The substantial reduction in net loss from $1.31 million to just $256,000 represents an 80% improvement in bottom-line performance.

The financial improvement stems from three key factors: revenue growth across all segments, consistent gross margins at 60.4%, and disciplined expense management. However, it's worth noting that $535,000 of "Other Income" contributed significantly to the bottom line this quarter - a non-recurring item that masks an operating loss of $754,000.

TOMI's product diversity is showing traction with SteraMist solution sales growing an impressive 197%, while service revenue increased 56%. Domestic revenue surged 80%, now comprising 75.6% of total sales, indicating strengthening position in the US market.

The growing backlog of $1.23 million (up $348,000 from December) suggests continued revenue momentum into upcoming quarters. Strategic expansion is evident with the $450,000 university contract and the NASA deployment, which opens doors to the aerospace sector.

While still operating at a loss, TOMI's trajectory shows classic turnaround indicators: accelerating revenue growth, improving margins, controlled expenses, and market expansion. The company's diversification strategy into multiple sectors (healthcare, academic, aerospace, and now aquaculture) reduces concentration risk while leveraging their core technology platform.

FREDERICK, Md., May 08, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.^® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its financial results for the first quarter ended March 31, 2025.

TOMI Chief Executive Officer, Dr. Halden Shane, stated, “The first quarter of 2025 delivered improved financial results as we grew quarter-over-quarter revenue by 42% and continue to see positive trends in the market with demand for our product lines and recurring solution sales. The increase in revenue, consistent gross profit and lower operating expenses all contributed to improved financial results for the first quarter of 2025, when compared to the same prior year period.

“We are off to a strong start thus far in 2025 and we expect to see similar trends for the remainder of 2025 and will continue to focus on executing our strategies to grow revenues, expand business development and deliver improved results and value for our shareholders,” Dr. Shane concluded.

Financial Results for the three months ended March 31, 2025, compared to March 31, 2024

• Sales, net was $1,577,000 compared to $1,114,000 for the three months ended March 31, 2025 and 2024, respectively.
  
  
• Gross margin was 60.4% compared to 60.2% in the prior year period.
  
  
• Operating loss was $(754,000), compared to $(1,226,000) in the prior year period.
  
  
• Net loss was $(256,000) or $(0.01) per basic and diluted share, compared to $(1,310,000) or $(0.07) per basic and diluted share in the same period last year.
  

Recent Business Highlights:

• SteraMist product-based revenues for the three months ended March 31, 2025 and 2024, were $1,000,000 and $743,000, respectively, representing an increase of $257,000 when compared to the same prior year period. The higher revenue was attributable to increased demand for our SteraMist BIT solution, mobile handheld point and spray product lines, the SteraMist Integrated System (SIS) product offering, scope adjustments to align with client needs and project dynamics on currently installed Custom Engineered Systems (CES’s) among deliverables to new projects.
• 197% quarter over quarter growth in SteraMist BIT solution sales for the first quarter of 2025, compared to the same prior year period.
• Service-based revenue for the three months ended March 31, 2025 and 2024, was $577,000 and $371,000, respectively, representing a year over year increase of $206,000, or 56%. The increase in service revenue was due to increased demand for iHP services as well as expanded services offered by the company.
• Domestic revenue for the three months ended March 31, 2025 and 2024 was $1,192,000 and $662,000, respectively, an increase of $530,000 or 80%, when compared to the same prior year period. Domestic revenue increased due to higher demand for our solution, mobile equipment, CES and iHP service sales.
• Sales backlog at March 31, 2025 was $1,225,000, representing an increase of $348,000 over the reported amount at December 31, 2024.
• In March 2025, the Company announced a significant contract to install a SteraMist iHP Custom Engineered System (CES) at a leading university in Rhode Island, valued at approximately $450,000. This new client was secured through distributor ARES Distribution, and underscores TOMI’s competitive advantage, having successfully outperformed key hydrogen peroxide competitors.
• The Company announced in March the deployment of SteraMist iHP technology at the NASA Johnson Space Center, marking the Company’s expansion into the aerospace sector, showcasing its potential for broader applications within the aerospace sector and beyond. This strategic partnership aligns with the Company’s ongoing SteraMistX campaign, which focuses on aerospace, military, and exploration fields utilizing iHP decontamination to elevate biosecurity biosafety standards.
• In March 2025, TOMI announced an OEM partnership with Pharma Biotech System Components LLC/Pharma Biotech System Components Ltd (PBSC), a premier manufacturer specializing in high containment, material decontamination, and cleanroom solutions. This collaboration enhances TOMI's SteraMist Integrated System (SIS) product launched in the second half of last year. Through this OEM agreement, TOMI will now offer pass-through hatches and chambers integrated with iHP, specifically designed for optimized decontamination cycles.
• On March 21, 2025, the Company announced the expansion into Aquaculture with new partner, Algafeed
  

Conference Call Information

TOMI will hold a conference call to discuss First Quarter 2025 results at 4:30 p.m. ET today, May 8, 2025.

To participate in the call by phone, dial (877) 545-0320 approximately five minutes prior to the scheduled start time and provide participant access code 616069, or request the "TOMI Environmental Solutions first quarter earnings call." International callers please dial (973) 528-0002. To access the live webcast or view the press release, please visit the Investor Relations section of the TOMI website or register at the following link: https://www.webcaster4.com/Webcast/Page/2262/52458.

A replay of the teleconference will be available until Thursday, May 22, 2025, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use replay access code: 52458. A replay of the webcast will be available for at least 90 days on the company’s website, starting approximately one hour after the completion of the call.

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.

Forward-Looking Statements

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, our strategies to grow revenue and expand business development, our expectation with respect to the remainder of 2025; our ability to generate lead and referral for sales, and our ability to improve financial performance. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

The following represents our consolidated balance sheets and statement of operations from our recently filed Form 10-Q:

TOMI ENVIRONMENTAL SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
ASSETS
Current Assets:	March 31, 2025 (Unaudited)				December 31, 2024
Cash and Cash Equivalents	$	674,181			$	664,879
Accounts Receivable – net		1,930,196				1,881,138
Other Receivables		455,010				-
Inventories, net		3,405,710				3,578,202
Vendor Deposits		32,915				35,895
Prepaid Expenses		281,480				332,999
Total Current Assets		6,779,492				6,493,113
Property and Equipment – net		818,304				875,449
Other Assets:
Intangible Assets – net		1,243,776				1,250,574
Operating Lease - Right of Use Asset		380,791				399,254
Other Assets		735,414				675,348
Total Other Assets		2,359,981				2,325,176
Total Assets	$	9,957,777			$	9,693,738
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts Payable	$	1,767,896			$	1,924,379
Accrued Expenses and Other Current Liabilities		878,084				455,675
Deferred Revenue		233,727				211,724
Current Portion of Long-Term Operating Lease		132,660				129,132
Total Current Liabilities		3,012,367				2,720,910
Long-Term Liabilities:
Long-Term Operating Lease, Net of Current Portion		479,357				513,395
Convertible Notes Payable, net of unamortized debt discount of $262,293 and $239,506 at March 31, 2025 and December 31, 2024, respectively		2,622,707				2,360,494
Total Long-Term Liabilities		3,102,064				2,873,889
Total Liabilities		6,114,431				5,594,799
Commitments and Contingencies		-				-
Shareholders’ Equity:
Cumulative Convertible Series A Preferred Stock; par value $0.01 per share, 1,000,000 shares authorized; 63,750 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively		638				638
Cumulative Convertible Series B Preferred Stock; $1,000 stated value; 7.5% Cumulative dividend; 4,000 shares authorized; none issued and outstanding at March 31, 2025 and December 31, 2024, respectively		-				-
Common stock; par value $0.01 per share, 250,000,000 shares authorized; 20,015,205 and 20,015,205 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively		200,152				200,152
Additional Paid-In Capital		58,201,140				58,201,140
Accumulated Deficit		(54,558,584	)			(54,302,991	)
Total Shareholders’ Equity		3,843,346				4,098,939
Total Liabilities and Shareholders’ Equity	$	9,957,777			$	9,693,738

	TOMI ENVIRONMENTAL SOLUTIONS, INC.
	CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
	(UNAUDITED)
	For The Three Months Ended
	March 31,
		2025				2024
Sales, net	$	1,576,558			$	1,114,087
Cost of Sales		624,813				443,419
Gross Profit		951,745				670,668
Operating Expenses:
Professional Fees		219,316				197,999
Depreciation and Amortization		68,542				77,921
Selling Expenses		246,406				289,069
Research and Development		44,580				67,971
Consulting Fees		102,766				113,635
General and Administrative		1,024,600				1,150,549
Total Operating Expenses		1,706,210				1,897,144
Income (loss) from Operations		(754,465	)			(1,226,476	)
Other Income (Expense):
Other Income		534,912				-
Interest Income		82,890				9,906
Interest Expense		(118,930	)			(93,620	)
Total Other Income (Expense)		498,872				(83,714	)
Income (loss) before income taxes		(255,593	)			(1,310,190	)
Provision for Income Taxes		-				-
Net Income (loss)	$	(255,593	)		$	(1,310,190	)
Net income (loss) Per Common Share
Basic	$	(0.01	)		$	(0.07	)
Diluted	$	(0.01	)		$	(0.07	)
Basic Weighted Average Common Shares Outstanding		20,015,205				19,954,511
Diluted Weighted Average Common Shares Outstanding		20,015,205				19,954,511

INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com

FAQ

What were TOMI Environmental Solutions (TOMZ) Q1 2025 earnings results?

TOMI reported Q1 2025 net sales of $1.58M (up 42% YoY), with a net loss of $256,000 or $0.01 per share, improved from a $1.31M loss in Q1 2024. Gross margin was 60.4%.

How much did TOMZ's SteraMist product revenue grow in Q1 2025?

SteraMist product revenue grew to $1M in Q1 2025 from $743,000 in Q1 2024, with SteraMist BIT solution sales specifically showing 197% quarter-over-quarter growth.

What new partnerships did TOMI Environmental announce in Q1 2025?

TOMI announced partnerships with NASA Johnson Space Center for aerospace applications and an OEM partnership with PBSC for cleanroom solutions. They also expanded into Aquaculture with new partner Algafeed.

What was TOMI Environmental's (TOMZ) sales backlog as of March 31, 2025?

TOMI's sales backlog was $1.225M as of March 31, 2025, representing an increase of $348,000 over December 31, 2024.

How much was TOMI's domestic revenue growth in Q1 2025?

TOMI's domestic revenue grew 80% year-over-year to $1.192M in Q1 2025, compared to $662,000 in Q1 2024.